Arteris VP Sells $66k in Stock via Pre-Scheduled 10b5-1 Plan
Arteris, Inc.
Subscribe to track AIP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Arteris VP Sells $66k in Stock via Pre-Scheduled 10b5-1 Plan
Company: Arteris, Inc. (AIP) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: Alpern Paul L Title: VP and General Counsel | Relationship: Officer
Transaction: • Type: Sell (following option exercise) • Shares: 5,000 • Price: $13.162 • Value: $65,810 • Owned After: 65,960
Key Insight: This is a routine, pre-planned sale under a 10b5-1 plan. The transaction size is immaterial, representing just 0.012% of the company's shares outstanding.
Market Context: Such pre-scheduled sales are common for executive compensation and diversification and typically carry little to no new information for the market.
Comprehensive Analysis
SEC Filing Analysis: Arteris, Inc. (AIP)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The VP and General Counsel of Arteris, Inc. conducted a routine, pre-planned "exercise and sell" transaction, disposing of 5,000 shares for a total of $65,810.
- Market Impact: Negligible, as the sale was executed under a 10b5-1 trading plan and represents an insignificant fraction of the company's market capitalization and shares outstanding.
Company Information
| Field | Value |
|---|---|
| Company | Arteris, Inc. |
| Ticker Symbol | AIP |
| CIK | 0001667011 |
| Industry | SEMICONDUCTORS & RELATED DEVICES |
Insider Information
| Field | Value |
|---|---|
| Name | Alpern Paul L |
| CIK | 0001888542 |
| Title/Position | VP and General Counsel |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 5,000 |
| Price Per Share | $13.162 |
| Total Value | $65,810 |
| Shares Owned After | 65,960 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $65,810 |
| % of Market Cap | 0.012% |
| Shares Transacted | 5,000 |
| % of Shares Outstanding | 0.012% |
| Post-Transaction Ownership | 65,960 shares (0.15% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $65,810 sale is immaterial against Arteris's market capitalization of $560 million.
- Ownership Concentration: The insider's post-transaction ownership of 0.15% is not a controlling stake, and the sale did not meaningfully change this position.
- Transaction Significance: The sale is insignificant, falling far below the thresholds for moderate or high significance (>0.1% of market cap or >0.1% of shares outstanding).
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction was executed under a pre-disclosed 10b5-1 plan, indicating it was scheduled in advance and not based on new, non-public information. The size is too small to have a market impact.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. Pre-planned sales for diversification or tax purposes do not signal a change in an insider's outlook on the company.
Additional Context
Special Circumstances
- 10b5-1 Plan: The filing explicitly states the sale was made pursuant to a 10b5-1 trading plan adopted on June 5, 2025. This removes the speculative element from the sale, as it was automated and pre-scheduled.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
